0001683168-22-008706.txt : 20221230
0001683168-22-008706.hdr.sgml : 20221230
20221230160537
ACCESSION NUMBER: 0001683168-22-008706
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221228
FILED AS OF DATE: 20221230
DATE AS OF CHANGE: 20221230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allen Daniel
CENTRAL INDEX KEY: 0001736605
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40699
FILM NUMBER: 221502030
MAIL ADDRESS:
STREET 1: 299 PARK AVENUE SOUTH
STREET 2: SUITE 90959
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc.
CENTRAL INDEX KEY: 0001157075
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621772151
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
BUSINESS PHONE: (917) 595.2850
MAIL ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
FORMER COMPANY:
FORMER CONFORMED NAME: NUVILEX, INC.
DATE OF NAME CHANGE: 20090324
FORMER COMPANY:
FORMER CONFORMED NAME: EFOODSAFETY COM INC
DATE OF NAME CHANGE: 20010808
4
1
ownership.xml
X0306
4
2022-12-28
1
0001157075
PharmaCyte Biotech, Inc.
PMCB
0001736605
Allen Daniel
C/O PHARMACYTE BIOTECH, INC.
3960 HOWARD HUGHES PARKWAY, SUITE 500
LAS VEGAS
NV
89169
1
0
0
0
Stock Option (Right to Buy)
2.97
2022-12-28
4
A
0
125000
0
A
2022-12-28
2032-11-14
Common Stock
125000
125000
D
The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the "2022 Plan"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022.
/s/ Daniel Allen
2022-12-30